Innovent Biologics, Inc.
Innovent Biologics, Inc. IVBXF Peers
See (IVBXF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IVBXF | $11.35 | -0.70% | 19.8B | -1200.00 | -$0.01 | N/A |
| NONOF | $66.81 | +3.46% | 283.6B | 17.27 | $3.70 | +2.56% |
| CSLLY | $86.83 | +3.59% | 162.3B | 30.69 | $2.73 | +1.58% |
| CMXHF | $173.54 | +7.31% | 77.5B | 29.30 | $5.46 | +1.73% |
| UCBJY | $101.39 | +0.09% | 38.5B | 31.41 | $3.22 | +0.78% |
| UCBJF | $202.16 | -0.83% | 37.7B | 30.67 | $6.46 | +1.54% |
| ARGNF | $547.60 | +0.00% | 33.4B | 33.43 | $16.37 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| SBMFF | $0.88 | -4.35% | 15.7B | 87.63 | $0.01 | +1.02% |
| WXXWY | $7.22 | -1.10% | 14.8B | 32.36 | $0.22 | N/A |
Stock Comparison
IVBXF vs NONOF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, NONOF has a market cap of 283.6B. Regarding current trading prices, IVBXF is priced at $11.35, while NONOF trades at $66.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas NONOF's P/E ratio is 17.27. In terms of profitability, IVBXF's ROE is -0.01%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, IVBXF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CSLLY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CSLLY has a market cap of 162.3B. Regarding current trading prices, IVBXF is priced at $11.35, while CSLLY trades at $86.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CSLLY's P/E ratio is 30.69. In terms of profitability, IVBXF's ROE is -0.01%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, IVBXF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CMXHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CMXHF has a market cap of 77.5B. Regarding current trading prices, IVBXF is priced at $11.35, while CMXHF trades at $173.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CMXHF's P/E ratio is 29.30. In terms of profitability, IVBXF's ROE is -0.01%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, IVBXF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs UCBJY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, UCBJY has a market cap of 38.5B. Regarding current trading prices, IVBXF is priced at $11.35, while UCBJY trades at $101.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas UCBJY's P/E ratio is 31.41. In terms of profitability, IVBXF's ROE is -0.01%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, IVBXF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs UCBJF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, UCBJF has a market cap of 37.7B. Regarding current trading prices, IVBXF is priced at $11.35, while UCBJF trades at $202.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas UCBJF's P/E ratio is 30.67. In terms of profitability, IVBXF's ROE is -0.01%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, IVBXF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ARGNF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ARGNF has a market cap of 33.4B. Regarding current trading prices, IVBXF is priced at $11.35, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ARGNF's P/E ratio is 33.43. In terms of profitability, IVBXF's ROE is -0.01%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, IVBXF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ODTC Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, IVBXF is priced at $11.35, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ODTC's P/E ratio is 1.07. In terms of profitability, IVBXF's ROE is -0.01%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, IVBXF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SBMFF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SBMFF has a market cap of 15.7B. Regarding current trading prices, IVBXF is priced at $11.35, while SBMFF trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SBMFF's P/E ratio is 87.63. In terms of profitability, IVBXF's ROE is -0.01%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, IVBXF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs WXXWY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, WXXWY has a market cap of 14.8B. Regarding current trading prices, IVBXF is priced at $11.35, while WXXWY trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas WXXWY's P/E ratio is 32.36. In terms of profitability, IVBXF's ROE is -0.01%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, IVBXF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SBHMY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SBHMY has a market cap of 14.6B. Regarding current trading prices, IVBXF is priced at $11.35, while SBHMY trades at $16.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SBHMY's P/E ratio is 56.21. In terms of profitability, IVBXF's ROE is -0.01%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, IVBXF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs GNMSF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, GNMSF has a market cap of 13.2B. Regarding current trading prices, IVBXF is priced at $11.35, while GNMSF trades at $208.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas GNMSF's P/E ratio is 12.58. In terms of profitability, IVBXF's ROE is -0.01%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, IVBXF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs WXIBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, WXIBF has a market cap of 12.9B. Regarding current trading prices, IVBXF is priced at $11.35, while WXIBF trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas WXIBF's P/E ratio is 28.91. In terms of profitability, IVBXF's ROE is -0.01%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, IVBXF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs TRSBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, TRSBF has a market cap of 9.2B. Regarding current trading prices, IVBXF is priced at $11.35, while TRSBF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas TRSBF's P/E ratio is 32.50. In terms of profitability, IVBXF's ROE is -0.01%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, IVBXF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs TLPPF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, TLPPF has a market cap of 5.4B. Regarding current trading prices, IVBXF is priced at $11.35, while TLPPF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas TLPPF's P/E ratio is 160.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, IVBXF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ABCZF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, IVBXF is priced at $11.35, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, IVBXF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs AKBLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, AKBLF has a market cap of 5B. Regarding current trading prices, IVBXF is priced at $11.35, while AKBLF trades at $30.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas AKBLF's P/E ratio is 33.86. In terms of profitability, IVBXF's ROE is -0.01%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, IVBXF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs INCPF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, IVBXF is priced at $11.35, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas INCPF's P/E ratio is -108.67. In terms of profitability, IVBXF's ROE is -0.01%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, IVBXF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs LABFF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, IVBXF is priced at $11.35, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas LABFF's P/E ratio is 28.95. In terms of profitability, IVBXF's ROE is -0.01%, compared to LABFF's ROE of +0.38%. Regarding short-term risk, IVBXF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs GNNSF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, GNNSF has a market cap of 4.5B. Regarding current trading prices, IVBXF is priced at $11.35, while GNNSF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas GNNSF's P/E ratio is -25.87. In terms of profitability, IVBXF's ROE is -0.01%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, IVBXF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ZLDPF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, IVBXF is priced at $11.35, while ZLDPF trades at $55.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ZLDPF's P/E ratio is -21.32. In terms of profitability, IVBXF's ROE is -0.01%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, IVBXF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CAMRF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, IVBXF is priced at $11.35, while CAMRF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CAMRF's P/E ratio is 45.60. In terms of profitability, IVBXF's ROE is -0.01%, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, IVBXF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs GLPGF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, IVBXF is priced at $11.35, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas GLPGF's P/E ratio is -15.12. In terms of profitability, IVBXF's ROE is -0.01%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, IVBXF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs REGMF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, REGMF has a market cap of 3.1B. Regarding current trading prices, IVBXF is priced at $11.35, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas REGMF's P/E ratio is -13.32. In terms of profitability, IVBXF's ROE is -0.01%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, IVBXF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs TKBIF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, IVBXF is priced at $11.35, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, IVBXF's ROE is -0.01%, compared to TKBIF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs MPSYF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, IVBXF is priced at $11.35, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, IVBXF's ROE is -0.01%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, IVBXF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ONTTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ONTTF has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $11.35, while ONTTF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ONTTF's P/E ratio is -10.76. In terms of profitability, IVBXF's ROE is -0.01%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, IVBXF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BVNRY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BVNRY has a market cap of 2.2B. Regarding current trading prices, IVBXF is priced at $11.35, while BVNRY trades at $9.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BVNRY's P/E ratio is 10.93. In terms of profitability, IVBXF's ROE is -0.01%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, IVBXF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ASPHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, IVBXF is priced at $11.35, while ASPHF trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, IVBXF's ROE is -0.01%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, IVBXF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BVNKF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BVNKF has a market cap of 2.2B. Regarding current trading prices, IVBXF is priced at $11.35, while BVNKF trades at $28.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BVNKF's P/E ratio is 10.82. In terms of profitability, IVBXF's ROE is -0.01%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, IVBXF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SHJBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SHJBF has a market cap of 2.1B. Regarding current trading prices, IVBXF is priced at $11.35, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, IVBXF's ROE is -0.01%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, IVBXF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs IUGNF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, IVBXF is priced at $11.35, while IUGNF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, IVBXF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs GENSF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, IVBXF is priced at $11.35, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas GENSF's P/E ratio is -289.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, IVBXF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PHMMF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, IVBXF is priced at $11.35, while PHMMF trades at $92.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PHMMF's P/E ratio is 72.88. In terms of profitability, IVBXF's ROE is -0.01%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, IVBXF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BRCTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, IVBXF is priced at $11.35, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BRCTF's P/E ratio is 17.76. In terms of profitability, IVBXF's ROE is -0.01%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, IVBXF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BIESF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, IVBXF is priced at $11.35, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BIESF's P/E ratio is -44.44. In terms of profitability, IVBXF's ROE is -0.01%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, IVBXF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PPTDF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, IVBXF is priced at $11.35, while PPTDF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PPTDF's P/E ratio is 14.38. In terms of profitability, IVBXF's ROE is -0.01%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, IVBXF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CSBTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CSBTF has a market cap of 1.4B. Regarding current trading prices, IVBXF is priced at $11.35, while CSBTF trades at $35.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CSBTF's P/E ratio is -300.08. In terms of profitability, IVBXF's ROE is -0.01%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, IVBXF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ASCLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, IVBXF is priced at $11.35, while ASCLF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, IVBXF's ROE is -0.01%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, IVBXF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs NURPF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, NURPF has a market cap of 1.2B. Regarding current trading prices, IVBXF is priced at $11.35, while NURPF trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas NURPF's P/E ratio is 14.20. In terms of profitability, IVBXF's ROE is -0.01%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, IVBXF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs MEOBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, IVBXF is priced at $11.35, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas MEOBF's P/E ratio is -16.08. In terms of profitability, IVBXF's ROE is -0.01%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, IVBXF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SNBIF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, IVBXF is priced at $11.35, while SNBIF trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SNBIF's P/E ratio is -49.24. In terms of profitability, IVBXF's ROE is -0.01%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, IVBXF is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BTTAY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BTTAY has a market cap of 958.8M. Regarding current trading prices, IVBXF is priced at $11.35, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, IVBXF's ROE is -0.01%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, IVBXF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs HBMHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, HBMHF has a market cap of 766.2M. Regarding current trading prices, IVBXF is priced at $11.35, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas HBMHF's P/E ratio is 30.16. In terms of profitability, IVBXF's ROE is -0.01%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, IVBXF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs IDRSF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, IDRSF has a market cap of 734.9M. Regarding current trading prices, IVBXF is priced at $11.35, while IDRSF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas IDRSF's P/E ratio is -2.12. In terms of profitability, IVBXF's ROE is -0.01%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, IVBXF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PHGUF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PHGUF has a market cap of 685.1M. Regarding current trading prices, IVBXF is priced at $11.35, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, IVBXF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SYGGF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SYGGF has a market cap of 675.7M. Regarding current trading prices, IVBXF is priced at $11.35, while SYGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SYGGF's P/E ratio is -0.47. In terms of profitability, IVBXF's ROE is -0.01%, compared to SYGGF's ROE of -0.62%. Regarding short-term risk, IVBXF is more volatile compared to SYGGF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs AAVXF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, AAVXF has a market cap of 655.2M. Regarding current trading prices, IVBXF is priced at $11.35, while AAVXF trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas AAVXF's P/E ratio is -2.99. In terms of profitability, IVBXF's ROE is -0.01%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, IVBXF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BPMUF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BPMUF has a market cap of 636.8M. Regarding current trading prices, IVBXF is priced at $11.35, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BPMUF's P/E ratio is 7.04. In terms of profitability, IVBXF's ROE is -0.01%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, IVBXF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SOLTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SOLTF has a market cap of 561.1M. Regarding current trading prices, IVBXF is priced at $11.35, while SOLTF trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SOLTF's P/E ratio is -36.47. In terms of profitability, IVBXF's ROE is -0.01%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, IVBXF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs INRLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, IVBXF is priced at $11.35, while INRLF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas INRLF's P/E ratio is -4.92. In terms of profitability, IVBXF's ROE is -0.01%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, IVBXF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CLAZF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CLAZF has a market cap of 531.7M. Regarding current trading prices, IVBXF is priced at $11.35, while CLAZF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CLAZF's P/E ratio is 0.09. In terms of profitability, IVBXF's ROE is -0.01%, compared to CLAZF's ROE of +0.00%. Regarding short-term risk, IVBXF is more volatile compared to CLAZF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs IVEVF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, IVBXF is priced at $11.35, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, IVBXF's ROE is -0.01%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, IVBXF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CKDXF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CKDXF has a market cap of 480.8M. Regarding current trading prices, IVBXF is priced at $11.35, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, IVBXF's ROE is -0.01%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, IVBXF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs VBIZF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, VBIZF has a market cap of 472.2M. Regarding current trading prices, IVBXF is priced at $11.35, while VBIZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, IVBXF's ROE is -0.01%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, IVBXF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs GSGTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, GSGTF has a market cap of 469.5M. Regarding current trading prices, IVBXF is priced at $11.35, while GSGTF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas GSGTF's P/E ratio is -8.16. In terms of profitability, IVBXF's ROE is -0.01%, compared to GSGTF's ROE of +0.78%. Regarding short-term risk, IVBXF is more volatile compared to GSGTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs MDCLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, MDCLF has a market cap of 463M. Regarding current trading prices, IVBXF is priced at $11.35, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, IVBXF's ROE is -0.01%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, IVBXF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs RAONF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, IVBXF is priced at $11.35, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas RAONF's P/E ratio is -43.33. In terms of profitability, IVBXF's ROE is -0.01%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, IVBXF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BOVNF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, IVBXF is priced at $11.35, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BOVNF's P/E ratio is -8.84. In terms of profitability, IVBXF's ROE is -0.01%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, IVBXF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CSPHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CSPHF has a market cap of 435.6M. Regarding current trading prices, IVBXF is priced at $11.35, while CSPHF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, IVBXF's ROE is -0.01%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, IVBXF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs TBGNF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, IVBXF is priced at $11.35, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, IVBXF's ROE is -0.01%, compared to TBGNF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PTCHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PTCHF has a market cap of 425.2M. Regarding current trading prices, IVBXF is priced at $11.35, while PTCHF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PTCHF's P/E ratio is 8.43. In terms of profitability, IVBXF's ROE is -0.01%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, IVBXF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CLVLY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CLVLY has a market cap of 388.5M. Regarding current trading prices, IVBXF is priced at $11.35, while CLVLY trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CLVLY's P/E ratio is 15.50. In terms of profitability, IVBXF's ROE is -0.01%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, IVBXF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CYDY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CYDY has a market cap of 364.5M. Regarding current trading prices, IVBXF is priced at $11.35, while CYDY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CYDY's P/E ratio is -14.79. In terms of profitability, IVBXF's ROE is -0.01%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, IVBXF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CLVLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CLVLF has a market cap of 363.4M. Regarding current trading prices, IVBXF is priced at $11.35, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CLVLF's P/E ratio is 14.50. In terms of profitability, IVBXF's ROE is -0.01%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, IVBXF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs NWBO Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, NWBO has a market cap of 363M. Regarding current trading prices, IVBXF is priced at $11.35, while NWBO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas NWBO's P/E ratio is -4.15. In terms of profitability, IVBXF's ROE is -0.01%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, IVBXF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs HLOSF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, HLOSF has a market cap of 331.8M. Regarding current trading prices, IVBXF is priced at $11.35, while HLOSF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas HLOSF's P/E ratio is -10.23. In terms of profitability, IVBXF's ROE is -0.01%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, IVBXF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PRRUF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PRRUF has a market cap of 322.9M. Regarding current trading prices, IVBXF is priced at $11.35, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PRRUF's P/E ratio is -11.05. In terms of profitability, IVBXF's ROE is -0.01%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, IVBXF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PBBIF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, IVBXF is priced at $11.35, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, IVBXF's ROE is -0.01%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, IVBXF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CLTEF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CLTEF has a market cap of 284.1M. Regarding current trading prices, IVBXF is priced at $11.35, while CLTEF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CLTEF's P/E ratio is -3.97. In terms of profitability, IVBXF's ROE is -0.01%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, IVBXF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs HNSBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, HNSBF has a market cap of 279.7M. Regarding current trading prices, IVBXF is priced at $11.35, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas HNSBF's P/E ratio is -3.75. In terms of profitability, IVBXF's ROE is -0.01%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, IVBXF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BXPHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BXPHF has a market cap of 277.1M. Regarding current trading prices, IVBXF is priced at $11.35, while BXPHF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BXPHF's P/E ratio is -14.13. In terms of profitability, IVBXF's ROE is -0.01%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, IVBXF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs GNFTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, GNFTF has a market cap of 276.4M. Regarding current trading prices, IVBXF is priced at $11.35, while GNFTF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas GNFTF's P/E ratio is 13.87. In terms of profitability, IVBXF's ROE is -0.01%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, IVBXF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PRNAF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PRNAF has a market cap of 276.2M. Regarding current trading prices, IVBXF is priced at $11.35, while PRNAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, IVBXF's ROE is -0.01%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, IVBXF is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs TRGNF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, TRGNF has a market cap of 264.8M. Regarding current trading prices, IVBXF is priced at $11.35, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas TRGNF's P/E ratio is -5.88. In terms of profitability, IVBXF's ROE is -0.01%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, IVBXF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs AVCTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, AVCTF has a market cap of 241M. Regarding current trading prices, IVBXF is priced at $11.35, while AVCTF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas AVCTF's P/E ratio is -5.19. In terms of profitability, IVBXF's ROE is -0.01%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, IVBXF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs OPORF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, IVBXF is priced at $11.35, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas OPORF's P/E ratio is 17.50. In terms of profitability, IVBXF's ROE is -0.01%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, IVBXF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ORYZF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, IVBXF is priced at $11.35, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, IVBXF's ROE is -0.01%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, IVBXF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs NWPHF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, IVBXF is priced at $11.35, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas NWPHF's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is -0.01%, compared to NWPHF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SLNCF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, IVBXF is priced at $11.35, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, IVBXF's ROE is -0.01%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, IVBXF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SPHDF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SPHDF has a market cap of 212.7M. Regarding current trading prices, IVBXF is priced at $11.35, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SPHDF's P/E ratio is -3.52. In terms of profitability, IVBXF's ROE is -0.01%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, IVBXF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs FPHAF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, IVBXF is priced at $11.35, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, IVBXF's ROE is -0.01%, compared to FPHAF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs VSBC Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, IVBXF is priced at $11.35, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas VSBC's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is -0.01%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, IVBXF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs FGHQF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, IVBXF is priced at $11.35, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, IVBXF's ROE is -0.01%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, IVBXF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs NGENF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, NGENF has a market cap of 203.9M. Regarding current trading prices, IVBXF is priced at $11.35, while NGENF trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas NGENF's P/E ratio is -10.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, IVBXF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs AMGXF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, AMGXF has a market cap of 191.3M. Regarding current trading prices, IVBXF is priced at $11.35, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, IVBXF's ROE is -0.01%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, IVBXF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BRIBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BRIBF has a market cap of 190.3M. Regarding current trading prices, IVBXF is priced at $11.35, while BRIBF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BRIBF's P/E ratio is -2.60. In terms of profitability, IVBXF's ROE is -0.01%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, IVBXF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs CMVLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, IVBXF is priced at $11.35, while CMVLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, IVBXF's ROE is -0.01%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, IVBXF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs IPHYF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, IPHYF has a market cap of 179.7M. Regarding current trading prices, IVBXF is priced at $11.35, while IPHYF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas IPHYF's P/E ratio is -2.71. In terms of profitability, IVBXF's ROE is -0.01%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, IVBXF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs BSEM Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, BSEM has a market cap of 177.3M. Regarding current trading prices, IVBXF is priced at $11.35, while BSEM trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas BSEM's P/E ratio is 7.38. In terms of profitability, IVBXF's ROE is -0.01%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, IVBXF is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ADOCY Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, IVBXF is priced at $11.35, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, IVBXF's ROE is -0.01%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, IVBXF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs MLLCF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, IVBXF is priced at $11.35, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas MLLCF's P/E ratio is -1.99. In terms of profitability, IVBXF's ROE is -0.01%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, IVBXF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs RECEF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, RECEF has a market cap of 150M. Regarding current trading prices, IVBXF is priced at $11.35, while RECEF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas RECEF's P/E ratio is -8.33. In terms of profitability, IVBXF's ROE is -0.01%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, IVBXF is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs HOFBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, IVBXF is priced at $11.35, while HOFBF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to HOFBF's ROE of -1.54%. Regarding short-term risk, IVBXF is more volatile compared to HOFBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs AAPGV Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, IVBXF is priced at $11.35, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas AAPGV's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is -0.01%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, IVBXF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs SCNLF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, SCNLF has a market cap of 123.4M. Regarding current trading prices, IVBXF is priced at $11.35, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas SCNLF's P/E ratio is -3.97. In terms of profitability, IVBXF's ROE is -0.01%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, IVBXF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs PSTTF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, IVBXF is priced at $11.35, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, IVBXF's ROE is -0.01%, compared to PSTTF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs EPRXF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, IVBXF is priced at $11.35, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, IVBXF's ROE is -0.01%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, IVBXF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs POLBF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, POLBF has a market cap of 105.3M. Regarding current trading prices, IVBXF is priced at $11.35, while POLBF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas POLBF's P/E ratio is -7.55. In terms of profitability, IVBXF's ROE is -0.01%, compared to POLBF's ROE of -0.33%. Regarding short-term risk, IVBXF is more volatile compared to POLBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.
IVBXF vs ADOIF Comparison
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 19.8B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, IVBXF is priced at $11.35, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of -1200.00, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, IVBXF's ROE is -0.01%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, IVBXF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.